mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.02 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.02 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.03 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.03 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.03 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.03 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.03 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.03 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |